top
Search terms
Results 1 - 4 of 4 - ordered by :
Ejhf

PrognosisAuthors O'Connor Christopher M., Corresponding authorDuke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA Corresponding author: Tel: +1 919 681 6195, Fax: +1 ...

European Journal of Heart Failure, O'Connor, Christopher M., Mentz, Robert J., Cotter, Gad, Metra, Marco, Cleland, John G., Davison, Beth A., Givertz, Michael M., Mansoor, George A., Ponikowski, ...

Date : 01/06/2012 Item size : 200329 bytes
Ejhf

Beneficial responses to medications and devices used in the treatment of HF are associated with decreases in plasma BNP, and intensified treatment directed at reducing BNP may improve outcomes. [4] ...

European Journal of Heart Failure, Wollert, Kai C., Kempf, Tibor

Date : 01/11/2012 Item size : 88491 bytes
Ejhf

PrognosisAuthors O'Connor Christopher M., Corresponding authorDuke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA Corresponding author: Tel: +1 919 681 6195, Fax: +1 ...

European Journal of Heart Failure, O'Connor, Christopher M., Mentz, Robert J., Cotter, Gad, Metra, Marco, Cleland, John G., Davison, Beth A., Givertz, Michael M., Mansoor, George A., Ponikowski, ...

Date : 01/06/2012 Item size : 199603 bytes
Ejhf

There is a growing interest in using circulating biomarkers to obtain pathophysiological insight and improve the management of patients with heart failure (HF). Beneficial responses to medications ...

European Journal of Heart Failure, Wollert, Kai C., Kempf, Tibor

Date : 01/11/2012 Item size : 91525 bytes